Table 2 Agreement between QFT-GIT and TST, stratified by BCG vaccination status
| Â | Â | QFT-GIT, n (%) | ||
|---|---|---|---|---|
| Â | TST >5 mm | Positive | Negative | Agreement |
All subjects | Positive | 7 (4.9) | 33 (23.1) | Raw = 72.7% |
| Â | Negative | 6 (4.2) | 97 (67.8) | Îş = 0.15 |
BCG vaccinated | Positive | 3 (4.1) | 22 (30.1) | Raw = 64.4% |
| Â | Negative | 4 (5.5) | 44 (60.3) | Îş = 0.04 |
No BCG | Positive | 3 (5.4) | 7 (12.5) | Raw = 85.8% |
| Â | Negative | 1 (1.8) | 45 (80.4) | Îş = 0.36 |
| Â | TST >10 mm | Positive | Negative | Agreement |
All subjects | Positive | 7 (4.9) | 22 (15.4) | Raw = 79.7% |
| Â | Negative | 6 (4.2) | 108 (75.5) | Îş = 0.19 |
BCG vaccinated | Positive | 3 (4.1) | 15 (20.5) | Raw = 74.0% |
| Â | Negative | 4 (5.5) | 51 (69.9) | Îş = 0.12 |
No BCG | Positive | 2 (3.6) | 3 (5.4) | Raw = 91.1% |
| Â | Negative | 2 (3.6) | 49 (87.5) | Îş = 0.40 |